Half-year report · HY
4326.TEDINET S100XJA9
Period2025-07-01 → 2025-12-31
Filed2026-02-05
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥31.7bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥65.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥32.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.7bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.1bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.2bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.5bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.2bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥2.0bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥47.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥46.9bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥45.7bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥13.3bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥13.6bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥33.8bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥33.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥32.5bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.8bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.3bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.5bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥2.0bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.4bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥483m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥523m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥911m | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.1bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥31.95 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.83 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.88 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 71.3% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| Business Intelligencereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥3.4bn |
| Business Intelligencereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥3.4bn |
| Business Intelligencereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥186m |
| Marketing Support Consumer Goods And Servicesreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥21.8bn |
| Marketing Support Consumer Goods And Servicesreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥21.8bn |
| Marketing Support Consumer Goods And Servicesreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥631m |
| Marketing Support Healthcarereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥6.5bn |
| Marketing Support Healthcarereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥6.5bn |
| Marketing Support Healthcarereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥1.5bn |
| Business Intelligencereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥3.7bn |
| Business Intelligencereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥3.7bn |
| Business Intelligencereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥368m |
| Marketing Support Consumer Goods And Servicesreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥21.7bn |
| Marketing Support Consumer Goods And Servicesreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥21.7bn |
| Marketing Support Consumer Goods And Servicesreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥227m |
| Marketing Support Healthcarereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥6.6bn |
| Marketing Support Healthcarereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥6.6bn |
| Marketing Support Healthcarereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in investment activities | Prior1InterimDuration | 1400013000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -523067000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | － | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -100000000 | JPY |
| Repayments of lease obligations fin cf | Prior1InterimDuration | -83645000 | JPY |
| Repayments of lease obligations fin cf | InterimDuration | -76595000 | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | Prior1InterimDuration | 872000 | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | InterimDuration | 898000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -1655333000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -867779000 | JPY |
| Other net fin cf | Prior1InterimDuration | -38160000 | JPY |
| Other net fin cf | InterimDuration | -12809000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -1776267000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -1056286000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | -20419000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | 46947000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | 86053000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | -3567271000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 11940803000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 16492126000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 12026857000 | JPY |
| Cash and cash equivalents | InterimInstant | 12924855000 | JPY |
| Payroll and allowances sga | Prior1InterimDuration | 4133822000 | JPY |
| Payroll and allowances sga | InterimDuration | 4273091000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 913920000 | JPY |
| Provision for bonuses sga | InterimDuration | 947185000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 199170000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 213474000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportConsumerGoodsAndServicesReportableSegmentsMember | 21691312000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportHealthcareReportableSegmentsMember | 6609153000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05239-000BusinessIntelligenceReportableSegmentsMember | 3726834000 | JPY |
| Revenues from external customers | Prior1InterimDuration | 32027300000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportConsumerGoodsAndServicesReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportHealthcareReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05239-000BusinessIntelligenceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportConsumerGoodsAndServicesReportableSegmentsMember | 21691312000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportHealthcareReportableSegmentsMember | 6609153000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05239-000BusinessIntelligenceReportableSegmentsMember | 3726834000 | JPY |
| Net sales | Prior1InterimDuration | 32027300000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportConsumerGoodsAndServicesReportableSegmentsMember | 227189000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportHealthcareReportableSegmentsMember | 1186766000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05239-000BusinessIntelligenceReportableSegmentsMember | 367597000 | JPY |
| Operating income | Prior1InterimDuration | 1781552000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportConsumerGoodsAndServicesReportableSegmentsMember | 21790497000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportHealthcareReportableSegmentsMember | 6474556000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05239-000BusinessIntelligenceReportableSegmentsMember | 3423441000 | JPY |
| Revenues from external customers | InterimDuration | 31688495000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportConsumerGoodsAndServicesReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05239-000MarketingSupportHealthcareReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |